341 related articles for article (PubMed ID: 26699621)
21. Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.
Lim YS; Lee TH; Heo NY; Shim JH; Lee HC; Suh DJ
Antivir Ther; 2012; 17(1):53-60. PubMed ID: 22267469
[TBL] [Abstract][Full Text] [Related]
22. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
[TBL] [Abstract][Full Text] [Related]
23. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
[TBL] [Abstract][Full Text] [Related]
24. Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes.
Lee AR; Cho JY; Kim JC; Dezhbord M; Choo SY; Ahn CH; Kim NY; Shin JJ; Park S; Park ES; Won J; Kim DS; Lee JH; Kim KH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562603
[TBL] [Abstract][Full Text] [Related]
25. Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.
Januszkiewicz-Lewandowska D; Rucka A; Kowala-Piaskowska A; Bereszynska I; Mozer-Lisewska I; Zajac-Spychala O; Wysocki J; Nowak J
Acta Virol; 2014; 58(2):185-9. PubMed ID: 24957725
[TBL] [Abstract][Full Text] [Related]
26. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
27. [Tetracycline-inducible replications of wild-type and an adefovir-dipivoxil-resistant hepatitis B virus in human liver cells].
Wang JH; Wang XY; Fei R; Zhang HY; Wei L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):351-6. PubMed ID: 27029368
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.
Yuan HJ; Lee WM
Curr Mol Med; 2007 Mar; 7(2):185-97. PubMed ID: 17346170
[TBL] [Abstract][Full Text] [Related]
29. A novel method for the analysis of drug-resistant phenotypes of hepatitis B virus.
Qin B; He T; Chen Z; Xu W; Pan G; Tu C
Int J Mol Med; 2013 Apr; 31(4):975-81. PubMed ID: 23403838
[TBL] [Abstract][Full Text] [Related]
30. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
32. Clinical potential of emerging new agents in hepatitis B.
Farrell GC
Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196
[TBL] [Abstract][Full Text] [Related]
33. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
34. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
35. Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.
Betz-Stablein BD; Töpfer A; Littlejohn M; Yuen L; Colledge D; Sozzi V; Angus P; Thompson A; Revill P; Beerenwinkel N; Warner N; Luciani F
J Virol; 2016 Aug; 90(16):7171-7183. PubMed ID: 27252524
[TBL] [Abstract][Full Text] [Related]
36. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
37. Emerging drugs for the treatment of hepatitis B.
Fung J; Lai CL; Seto WK; Yuen MF
Expert Opin Emerg Drugs; 2016 Jun; 21(2):183-93. PubMed ID: 26940510
[TBL] [Abstract][Full Text] [Related]
38. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
Gomes-Gouvêa MS; Ferreira AC; Teixeira R; Andrade JR; Ferreira AS; Barros LM; Rezende RE; Nastri AC; Leite AG; Piccoli LZ; Galvan J; Conde SR; Soares MC; Kliemann DA; Bertolini DA; Kunyoshi AS; Lyra AC; Oikawa MK; de Araújo LV; Carrilho FJ; Mendes-Corrêa MC; Pinho JR
Antivir Ther; 2015; 20(4):387-95. PubMed ID: 25624410
[TBL] [Abstract][Full Text] [Related]
39. HBV Genome and Life Cycle.
Wang J; Huang H; Liu Y; Chen R; Yan Y; Shi S; Xi J; Zou J; Yu G; Feng X; Lu F
Adv Exp Med Biol; 2020; 1179():17-37. PubMed ID: 31741332
[TBL] [Abstract][Full Text] [Related]
40. Molecular genesis of drug-resistant and vaccine-escape HBV mutants.
Locarnini SA; Yuen L
Antivir Ther; 2010; 15(3 Pt B):451-61. PubMed ID: 20516565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]